September 17, 2015
Jardiance reduces cardiovascular death rate in T2D patients
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly reported that the Company’s Jardiance (empagliflozin) had reduced the risk of the…